About
Pharnext develops innovative drug repositioning therapies focusing on neurodegenerative diseases and rare diseases using its proprietary Pleotherapy platform.
Explore Pharnext's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.